VG9‐IL‐24 treatment also delayed MDA‐MB‐231 breast cancer tumor growth and proved effective in delaying tumor growth in xenograft mouse models using the cell line in vivo (Deng et al. 2020). This evidence concerns the gene IL24 and neoplasm.